{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T02:48:31Z","timestamp":1770432511713,"version":"3.49.0"},"reference-count":69,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2015,4,3]]},"DOI":"10.1517\/13543784.2015.1009976","type":"journal-article","created":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T05:54:26Z","timestamp":1422597266000},"page":"575-584","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Potential use of lurasidone for the treatment of bipolar psychosis"],"prefix":"10.1517","volume":"24","author":[{"given":"Mauro Giovanni","family":"Carta","sequence":"first","affiliation":[{"name":"University of Cagliari, Department of Public Health, Clinical and Molecular Medicine","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Francesca","family":"Moro","sequence":"additional","affiliation":[{"name":"University of Cagliari, Department of Public Health, Clinical and Molecular Medicine","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio E","family":"Nardi","sequence":"additional","affiliation":[{"name":"Federal University of Rio de Janeiro, National Academy of Medicine, Medical School - Institute of Psychiatry","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph R","family":"Calabrese","sequence":"additional","affiliation":[{"name":"Mood Disorders Program Case Western Reserve School of Medicine","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,1,30]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2013.01.020"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.10060907"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.01.009"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2010.02587.x"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32835281ef"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.03.013"},{"key":"e_1_3_2_9_1","first-page":"161","article-title":"Lurasidone monotherapy in the treatment of bipolar i depression: a randomized, double-blind, placebo-controlled study","volume":"171","author":"Loebel A","year":"2014","unstructured":"Loebel A, Cucchiaro J, Silva R, et al. Lurasidone monotherapy in the treatment of bipolar i depression: a randomized, double-blind, placebo-controlled study. Am J Psychiatry 2014;171:161-8","journal-title":"Am J Psychiatry"},{"key":"e_1_3_2_10_1","first-page":"2","article-title":"Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar i depression: a randomized, double-blind, placebo-controlled study","volume":"171","author":"Loebel A","year":"2014","unstructured":"Loebel A, Cucchiaro J, Silva R, et al. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar i depression: a randomized, double-blind, placebo-controlled study. Am J Psychiatry 2014;171:2","journal-title":"Am J Psychiatry"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.167346"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.06.058"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.01.023"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1517\/17460441.2013.815163"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M721"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543780903286388"},{"key":"e_1_3_2_17_1","volume-title":"Rang & Dale\u2019s pharmacology","author":"Flower R","year":"2007","unstructured":"Flower R, Rang HP, Dale MM, et al. Rang & Dale\u2019s pharmacology. Edinburgh; Churchill Livingstone: 2007; ISBN 0-443-06911-5"},{"key":"e_1_3_2_18_1","unstructured":"DA. Drug Interactions: cytochrome P450 Drug Interaction Table. Indiana University School of Medicine. 2007. Available from: http:\/\/medicine.iupui.edu\/clinpharm\/ddis\/table.asp"},{"key":"e_1_3_2_19_1","unstructured":"FASS. Swedish environmental classification of pharmaceuticals Facts for prescribers (Fakta f\u00f6r f\u00f6rskrivare). http:\/\/www.fass.se\/LIF\/healthcarefacts?userType=0 Retrieved July 2014"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04905"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60733-3"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12m07992"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125311420752"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200822050-00003"},{"key":"e_1_3_2_25_1","article-title":"Predictors of placebo response in bipolar depression","author":"Nierenberg AA","year":"2014","unstructured":"Nierenberg AA, Ostergaard SD, Iovieno N, et al. Predictors of placebo response in bipolar depression. Int Clin Psychopharmacol 2014; Epub ahead of print","journal-title":"Int Clin Psychopharmacol"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(99)00311-X"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04152"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.612"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S18059"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.1394"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2013.10.004"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2014.05.011"},{"key":"e_1_3_2_33_1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1139\/jpn.0849","article-title":"Effects of mood stabilizers on DNA damage in an animal model of mania","volume":"33","author":"Andreazza AC","year":"2008","unstructured":"Andreazza AC, Kauer-Sant\u2019Anna M, Frey BN, et al. Effects of mood stabilizers on DNA damage in an animal model of mania. J Psychiatry Neurosci 2008;33:516-24","journal-title":"J Psychiatry Neurosci"},{"issue":"3","key":"e_1_3_2_34_1","first-page":"680","article-title":"Gattaz, Machado-Vieira R: WF, Effects lithium oxidative stress parameters healthy subjects","volume":"5","author":"Khairova R","year":"2012","unstructured":"Khairova R, Pawar R, Salvadore G, et al. Gattaz, Machado-Vieira R: WF, Effects lithium oxidative stress parameters healthy subjects. Mol Med Rep 2012;5(3):680-2","journal-title":"Mol Med Rep"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2007.05.016"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2006.07.013"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.04.052"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145708009802"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-12-52"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.11.008"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.05.024"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.2174\/1745017901208010052"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2009.10030434"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2014.03.042"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/1744-9081-8-61"},{"issue":"5","key":"e_1_3_2_46_1","first-page":"231","article-title":"Multiaxial evaluation of the pathophysiology of mood disorder and therapeutic mechanisms of clinical drugs by neuronal plasticity and neuronal load","volume":"33","author":"Omata N","year":"2013","unstructured":"Omata N, Mizuno T, Mitsuya H, Wada Y. Multiaxial evaluation of the pathophysiology of mood disorder and therapeutic mechanisms of clinical drugs by neuronal plasticity and neuronal load. Nihon Shinkei Seishin Yakurigaku Zasshi 2013;33(5-6):231-6","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-0179-1-7"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.2174\/1745017901006010001"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.01.022"},{"key":"e_1_3_2_50_1","first-page":"1","article-title":"Evaluating aripiprazole as a potential bipolar disorder therapy for adults","author":"Moro MF","year":"2014","unstructured":"Moro MF, Carta MG. Evaluating aripiprazole as a potential bipolar disorder therapy for adults. Expert Opin Investig Drugs 2014;1-18; Epub ahead of print","journal-title":"Expert Opin Investig Drugs"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001040"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1521-8"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2012.01.010"},{"key":"e_1_3_2_54_1","first-page":"1","article-title":"Behavioural and neuroplastic properties of chronic lurasidone treatment in serotonin transporter knockout rats","volume":"20","author":"Luoni A","year":"2012","unstructured":"Luoni A, Hulsken S, Cazzaniga G, et al. Behavioural and neuroplastic properties of chronic lurasidone treatment in serotonin transporter knockout rats. Int J Neuropsychopharmcol 2012;20:1-12","journal-title":"Int J Neuropsychopharmcol"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.111.076141"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3864-08.2008"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-11-03993.2000"},{"key":"e_1_3_2_58_1","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hipo.20938","article-title":"The 5-HT(7) receptor in learning and memory","volume":"22","author":"Roberts AJ","year":"2012","unstructured":"Roberts AJ, Hedlund PB. The 5-HT(7) receptor in learning and memory. Hippocampus 2012;22:762-71","journal-title":"Hippocampus"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.10.001"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145711000150"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1186909"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-012-2900-0"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.221"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S51910"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13m08928"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109102919"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-014-0157-3"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31829e8168"},{"issue":"1","key":"e_1_3_2_69_1","first-page":"20","article-title":"Aging effects on QT interval: implications for cardiac safety of antipsychotic drugs","volume":"11","author":"Rabkin SW","year":"2014","unstructured":"Rabkin SW. Aging effects on QT interval: implications for cardiac safety of antipsychotic drugs. J Geriatr Cardiol 2014;11(1):20-5","journal-title":"J Geriatr Cardiol"},{"key":"e_1_3_2_70_1","first-page":"CD006625","article-title":"Quetiapine versus other atypical antipsychotics for schizophrenia","volume":"11","author":"Asmal L","year":"2013","unstructured":"Asmal L, Flegar SJ, Wang J, et al. Quetiapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev 2013;11:CD006625","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2012.02321.x"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.2015.1009976","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T13:32:50Z","timestamp":1770384770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.2015.1009976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,30]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4,3]]}},"alternative-id":["10.1517\/13543784.2015.1009976"],"URL":"https:\/\/doi.org\/10.1517\/13543784.2015.1009976","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-01-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}